首页> 外文OA文献 >Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy

【2h】

Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy

机译：Encorafenib / Binimetinib用于治疗BRAF-突变体的先进，不可切除或转移黑色素瘤：在治疗中的设计，开发和潜在的地方

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
James Sun; Jonathan S. Zager; Zeynep Eroglu;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 作用于骨基质的放射性药物在治疗骨转移前列腺癌中的潜在协同作用 [J] . Oliver Sartor 亚洲男性学杂志：英文版 . 2011,第003期
2. Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy [J] . James Sun, Jonathan S Zager, Zeynep Eroglu OncoTargets and therapy . 2018,第4期

机译：恩哥拉非尼/比米替尼用于治疗BRAF突变的晚期，不可切除或转移性黑色素瘤：设计，开发及潜在的治疗方法
3. The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use [J] . HanaiziZ., VanZwieten-BootB., CalvoG., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2012,第2期

机译：欧洲药物管理局对ipilimumab（Yervoy）用于治疗已接受过先前治疗的成年人的晚期（不可切除或转移性）黑色素瘤的评价：人类使用药品委员会的科学评估摘要
4. Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy [J] . Paolo Grassi, Elena Verzoni, Raffaele Ratta, Drug Design, Development and Therapy . 2016,第5期

机译：卡博替尼治疗晚期肾细胞癌：设计，开发及在治疗中的潜在位置
5. Implications of Chemo/Biochemotherapy In the Treatment of Metastatic Melanoma [C] . Sanjiv S. Agarwala International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：化疗/生物切除疗法在转移性黑素瘤治疗中的影响
6. The role of interleukin-8 receptors in human melanoma cells with different metastatic potentials. [D] . Rao, Sushma. 2003

机译：白细胞介素8受体在具有不同转移潜能的人黑素瘤细胞中的作用。
7. Encorafenib/binimetinib for the treatment of BRAF-mutant advanced unresectable or metastatic melanoma: design development and potential place in therapy [O] . James Sun, Jonathan S Zager, Zeynep Eroglu 2018

机译：恩哥拉非尼/比米替尼用于治疗BRAF突变的晚期不可切除或转移性黑色素瘤：设计开发及潜在的治疗方法
8. Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal [O] . Rachel Houten, Janette Greenhalgh, James Mahon, 2020

机译：与Binimetinib的Encorafenib用于治疗BRAF V600突变阳性不可切除或转移黑素瘤的患者：证据审查集团的观点，这是一个很好的单一技术评估

Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy

著录项

引文网络

相似文献

相关主题

期刊订阅